Efficacy of Milinqing in Combination with Terazosin for IIIB Type Prostatitis
Wen Zhang
Abstract
Wen Zhang
Abstract
OBJECTIVE:To observe the clinical efficacy of Milinqing in combination with terazosin for ⅢB type prostatitis.METHODS:60 cases met the criteria of ⅢB type prostatitis were enrolled.All patients were treated with Milinqing(3 capsules/time,tid.)plus terazosin(2 mg q.d)for 6 weeks.The curative efficacy was compared between the two groups with NIH-CPSI scores as index.RESULTS:The total NIH-CPSI scores were 25.3±1.9 before treatment vs.10.9±1.2 after treatment(P0.01);the NIH-CPSI scores for pain and discomfort were 13.9±1.4 before treatment vs.6.9±1.2 after treatment(P0.05);and the NIH-CPSI scores for urination symptoms were 6.0±1.1 vs.1.1±0.5(P0.05);and the scores for quality of life were 6.9±0.9 vs.1.8±0.6(P0.01).CONCLUSION:Treatment of ⅢB type prostatitis with Milinqing in combination with terazosin achieved satisfactory curative efficacy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To observe the clinical efficacy of Milinqing in combination with terazosin for ⅢB type prostatitis.METHODS:60 cases met the criteria of ⅢB type prostatitis were enrolled.All patients were treated with Milinqing(3 capsules/time,tid.)plus terazosin(2 mg q.d)for 6 weeks.The curative efficacy was compared between the two groups with NIH-CPSI scores as index.RESULTS:The total NIH-CPSI scores were 25.3±1.9 before treatment vs.10.9±1.2 after treatment(P0.01);the NIH-CPSI scores for pain and discomfort were 13.9±1.4 before treatment vs.6.9±1.2 after treatment(P0.05);and the NIH-CPSI scores for urination symptoms were 6.0±1.1 vs.1.1±0.5(P0.05);and the scores for quality of life were 6.9±0.9 vs.1.8±0.6(P0.01).CONCLUSION:Treatment of ⅢB type prostatitis with Milinqing in combination with terazosin achieved satisfactory curative efficacy.
Key concepts: Terazosin, Prostatitis, Medicine, Urology, Urination, Quality of life (healthcare), Combination therapy, Clinical efficacy